Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd.
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd. (BJ Zhongshuo) was established in 2001. Its former is a state-owned enterprise found by CNPIC of SINOPHARM. After business restructuring, it is now a rapid developing joint-stock enterprise. The sales centre of BJ Zhongshuo is located in Beijing, and responsible for selling specialized APIs and pharmaceutical intermediates both domestically and overseas. The business of BJ Zhongshuo covers more than 200 products, including the APIs and pharmaceutical intermediates related to Antivirus, Antineoplastics, Cardiovascular agents, Central Nervous System and Antibiotics, etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Product Name: Oxaliplatin
Alternate Name/Synonyms: Foloxatine, Transplatin, Eloxatin, Eloxatine, Elplat, RP 54780, Dacplat, Oxalato(1R,2R-cyclohexanediamine)platinum(II), Oxalatoplatin, Oxalatoplatinum
Description: Oxaliplatin is a third-generation, diaminocyclohexane-containing platinum anti-cancer drug. The anticancer activity and the antitumor specificity of oxaliplatin mainly depend on human organic cation transporters (OCT) 1 and OCT2.
Peptide Sequence: N/A
Appearance: Off-white solid
Formulation: N/A
CAS Number: 61825-94-3
Molecular Formula: C₈H₁₄N₂O₄Pt
Molecular Weight: 397.29
Purity: ≥99%
Solubility:DMSO
Storage Temp.: -20°C
Shipping Conditions: RT
Handling: Protect from light and air